Reaction
Asterixis reporting signals
As of the last recalculation, Asterixis appears in 1,046 FAERS reports alongside 32 co-occurring drug terms. The strongest observed disproportionality signal is VALPROATE SODIUM (PRR 40.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Valproate Sodium | 40 | 40.0 | 40.1 |
| Phenytoin | 37 | 36.5 | 36.6 |
| Lithium Carbonate | 26 | 31.2 | 31.3 |
| Valproic Acid | 35 | 22.8 | 22.9 |
| Rifaximin | 23 | 22.3 | 22.3 |
| Carbamazepine | 67 | 21.2 | 21.2 |
| Lithium | 26 | 21.0 | 21.0 |
| Lithium Bromatum | 26 | 21.0 | 21.0 |
| Standardized Senna Concentrate | 11 | 17.6 | 17.6 |
| Basiliximab | 10 | 17.1 | 17.1 |
| Phenobarbital | 12 | 16.7 | 16.7 |
| Vigabatrin | 12 | 16.6 | 16.6 |
| Valganciclovir Hydrochloride Powder, | 10 | 16.5 | 16.5 |
| Abacavir Sulfate | 8 | 16.5 | 16.5 |
| Lactulose | 30 | 16.0 | 16.0 |
| Primidone | 8 | 15.7 | 15.8 |
| Senna Leaf | 16 | 14.0 | 14.0 |
| Epoetin Alfa | 8 | 13.5 | 13.5 |
| Clobazam | 16 | 13.2 | 13.2 |
| Levetiracetam Injection | 45 | 12.0 | 12.0 |
| Levetiracetam In Sodium Chloride | 44 | 11.8 | 11.8 |
| Levetiracetam Oral | 44 | 11.8 | 11.8 |
| Sorafenib | 12 | 11.6 | 11.6 |
| Linagliptin | 10 | 11.0 | 11.0 |
| Raltegravir | 9 | 10.9 | 10.9 |
| Sofosbuvir | 10 | 10.2 | 10.2 |
| Mesna Injection | 4 | 9.7 | 9.7 |
| Mesna | 4 | 9.5 | 9.5 |
| Clozapine | 46 | 7.6 | 7.6 |
| Daptomycin | 3 | 6.5 | 6.5 |
| Ledipasvir And Sofosbuvir | 6 | 6.2 | 6.2 |
| Tapentadol Hydrochloride | 6 | 3.6 | 3.6 |